Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
Franzese C, Marini B, Baldaccini D, Badalamenti M, Navarria P, Bellu L, Franceschini D, Comito T, Clerici E, Teriaca MA, Massaro M, Di Cristina L, Lo Faro L, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: massaro m. J Cancer Res Clin Oncol. 2023 Jul;149(8):4411-4417. doi: 10.1007/s00432-022-04352-z. Epub 2022 Sep 15. J Cancer Res Clin Oncol. 2023. PMID: 36109401
Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
Franzese C, Stefanini S, Massaro M, Comito T, Navarria P, Clerici E, Teriaca A, Franceschini D, Reggiori G, Tomatis S, Lania A, Scorsetti M. Franzese C, et al. Among authors: massaro m. J Cancer Res Clin Oncol. 2021 Dec;147(12):3619-3625. doi: 10.1007/s00432-021-03807-z. Epub 2021 Sep 18. J Cancer Res Clin Oncol. 2021. PMID: 34537907 Clinical Trial.
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy.
Massaro M, Franceschini D, Spoto R, Dominici L, Franzese C, Baldaccini D, Marini B, di Cristina L, Marzo MA, Lo Faro L, Paganini L, Reggiori G, Galdieri C, Testori A, Scorsetti M. Massaro M, et al. Curr Oncol. 2022 Jul 12;29(7):4893-4901. doi: 10.3390/curroncol29070388. Curr Oncol. 2022. PMID: 35877248 Free PMC article.
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors.
Franceschini D, Teriaca MA, Di Cristina L, Vernier V, Lo Faro L, Franzese C, Comito T, Clerici E, Bellu L, Dominici L, Spoto R, Massaro M, Navarria P, Scorsetti M. Franceschini D, et al. Among authors: massaro m. Br J Radiol. 2023 Mar 1;96(1144):20220771. doi: 10.1259/bjr.20220771. Epub 2023 Mar 3. Br J Radiol. 2023. PMID: 36809197 Free PMC article.
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
DE Sanctis V, DI Rocco A, Cox MC, Valeriani M, Congedi FP, Anzellini D, Massaro M, Vullo G, Facondo G, DE Giacomo F, Alfò M, Prosperi D, Pizzichini P, Pelliccia S, Tafuri A, Martelli M, Osti MF. DE Sanctis V, et al. Among authors: massaro m. In Vivo. 2020 May-Jun;34(3):1407-1413. doi: 10.21873/invivo.11921. In Vivo. 2020. PMID: 32354938 Free PMC article.
Role of prophylactic central neck dissection in cN0 papillary thyroid cancer.
Costa S, Giugliano G, Santoro L, Ywata De Carvalho A, Massaro MA, Gibelli B, De Fiori E, Grosso E, Ansarin M, Calabrese L. Costa S, et al. Among authors: massaro ma. Acta Otorhinolaryngol Ital. 2009 Apr;29(2):61-9. Acta Otorhinolaryngol Ital. 2009. PMID: 20111614 Free PMC article.
374 results